Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116668) titled 'SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study' on Aug. 7.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: SafeHeal Inc

Condition: Colorectal Cancer Stoma - Ileostomy

Intervention: Device: Colovac Anastomosis Protection Device placement following low anterior resection of colon cancer

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2025

Target Sample Size: 108

To know more, visit https://clinicaltrials.gov/ct2/show/NC...